January 18, 2018: Consultation on the Naming of Biologic Drugs is Open: January 18 to February 9, 2018You are invited to provide input on 3 options for the naming of biologic drugs, including biosimilars, in Canada. The consultation questionnaire consists of 5 questions.
Your responses to this consultation questionnaire will help to inform the development of Health Canada's naming policy to distinguish among biologic drugs that share the same non-proprietary name.
Access the Consultation and Questionnaire
For more information, for assistance, or to add other names to the distribution list, please send an e-mail to email@example.com.